Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.380
+0.010 (0.73%)
Nov 21, 2024, 4:00 PM EST - Market closed
Compass Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 190 | 199 | 633 | 309 | - | - | |
| Market Cap Growth | 0.88% | -68.61% | 105.02% | - | - | - | |
| Enterprise Value | 60 | 37 | 516 | 292 | - | - | |
| Last Close Price | 1.37 | 1.56 | 5.03 | 3.17 | - | - | |
| PB Ratio | 1.36 | 1.34 | 3.49 | 2.21 | - | - | |
| P/TBV Ratio | 1.83 | 1.34 | 3.49 | 2.21 | - | - | |
| Debt / Equity Ratio | 0.05 | 0.01 | 0.02 | 0.03 | 0.23 | 1.36 | |
| Quick Ratio | 30.54 | 19.54 | 11.54 | 13.59 | 4.66 | 2.58 | |
| Current Ratio | 31.84 | 19.73 | 12.05 | 13.84 | 4.97 | 2.67 | |
| Return on Equity (ROE) | -32.00% | -25.74% | -24.38% | -91.30% | -115.21% | -123.29% | |
| Return on Assets (ROA) | -21.71% | -17.66% | -14.73% | -19.00% | -42.25% | -44.80% | |
| Return on Capital (ROIC) | -22.55% | -18.80% | -15.84% | -20.21% | -45.80% | -49.00% | |
| Earnings Yield | -25.15% | -21.37% | -6.19% | -26.60% | - | - | |
| FCF Yield | -25.33% | -20.44% | -5.42% | -6.98% | - | - | |
| Buyback Yield / Dilution | -8.22% | -20.76% | -67.31% | -104.28% | -359.96% | - | |
| Total Shareholder Return | -8.22% | -20.76% | -67.31% | -104.28% | -359.96% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.